US Patent Issued to KUWAIT UNIVERSITY on March 18 for "Sulforaphane-cysteine for wound healing in diabetic subjects" (Kuwaiti Inventor)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,366, issued on March 18, was assigned to KUWAIT UNIVERSITY (Safat, Kuwait).

"Sulforaphane-cysteine for wound healing in diabetic subjects" was invented by Milad S. Bitar (Safat, Kuwait).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of healing a wound in a patient, can include administering to a patient in need thereof a therapeutically effective amount of Sulforaphane-Cysteine (SFN-Cys). The therapeutically effective amount may be 1.5 MuM. The SFN-Cys may be combined with an excipient and the excipient may be a poloxamer. The SFN-Cys, combined with a poloxamer, may be applied topically or taken orally."

The patent was filed on July 5, 202...